Genprex, Inc.
NASDAQ:GNPX
Overview | Financials
Company Name | Genprex, Inc. |
Symbol | GNPX |
Currency | USD |
Price | 0.738 |
Market Cap | 6,278,956 |
Dividend Yield | 0% |
52-week-range | 0.281 - 13 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. John Rodney Varner |
Website | https://www.genprex.com |
An error occurred while fetching data.
About Genprex, Inc.
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD